Abstract
Purpose of Review and Recent Findings
Sjögren syndrome (SS) is a systemic autoimmune disease characterized by exocrine gland dysfunction: xerostomia and xerophthalmia are the main symptoms. The reduction of salivary flow rate causes a dysbiosis of oral environment that may increase the risk of periodontal disease. The purpose of this narrative review was to analyze the current evidence of scientific literature on the relationship between periodontal disease and the Sjögren syndrome.
Material and Methods
A search on MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Web of Science databases was conducted to find all pertinent articles published. The searches were confined to full-text articles with no restriction of language or publication date. The selected studies and relevant articles were checked for cross-references. The remaining articles were evaluated by reading the full text independently.
Results
In total, 21 studies were included in the present literature review (8 previous reviews, 2 systematic reviews, 11 in vivo clinical studies). Some of these studies claimed a strong association between SS and increased risk of periodontal disease; furthermore, periodontal treatment seems to improve SS oral symptoms. Pilocarpine and other systemic drugs for SS increase SFR, by modifying oral microbiome of SS patients, versus normal.
Summary and Conclusions
A high level of evidence on the effects of SS on periodontal disease is missing; at present, there is not a state of the art on relationship between SS and incidence of periodontal disease.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ. 2012;344:e3821.
Valim V, Zandonade E, Pereira AM, de Brito Filho OH, Serrano EV, Musso C, Giovelli RA, Ciconelli RM. Primary Sjögren’s syndrome prevalence in a major metropolitan area in Brazil. Rev Bras Reumatol. 2013;53(1):24–34.
Soto-Rojas AE, Kraus A. The oral side of Sjögren syndrome. Diagnosis and treatment. A review. Arch Med Res. 2002;33(2):95–106.
Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren’s syndrome: a prospective cohort study. Arthritis Rheum. 2004;50(4):1262–9.
Antoniazzi RP, Miranda LA, Zanatta FB, Islabão AG, Gustafsson A, Chiapinotto GA, Oppermann RV. Periodontal conditions of individuals with Sjögren’s syndrome. J Periodontol. 2009;80(3):429–35.
Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. 1965. Medicine (Baltimore). 1992;71(6):386–401.
De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2019;195(1):74–85.
Celenligil H, Eratalay K, Kansu E, Ebersole JL. Periodontal status and serum antibody responses to oral microorganisms in Sjögren’s syndrome. J Periodontol. 1998;69(5):571–7.
Ambrósio LM, Rovai ES, França BN, Balzarini DA, Abreu IS, Lopes SB, Nunes TB, Lourenço SV, Pasoto SG, Saraiva L, Holzhausen M. Effects of periodontal treatment on primary Sjȫgren’s syndrome symptoms. Braz Oral Res. 2017;31:e8 States what we know today in current literature.
Fox PC, Speight PM. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren’s syndrome. Crit Rev Oral Biol Med. 1996;7(2):144–58.
Boutsi EA, Paikos S, Dafni UG, Moutsopoulos HM, Skopouli FN. Dental and periodontal status of Sjögren’s syndrome. J Clin Periodontol. 2000;27(4):231–5.
Schiødt M, Christensen LB, Petersen PE, Thorn JJ. Periodontal disease in primary Sjögren’s syndrome. Oral Dis. 2001;7(2):106–8.
Maarse F, Jager DHJ, Alterch S, Korfage A, Forouzanfar T, Vissink A, Brand HS. Sjögren’s syndrome is not a risk factor for periodontal disease: a systematic review. Clin Exp Rheumatol. 2019;37 Suppl 118(3):225–33. States what we know today in current literature.
Scardina GA, Ruggieri A, Messina P. Periodontal disease and Sjogren syndrome: a possible correlation? Angiology. 2010;61(3):289–93.
de Goés SL, Rocha RL, Bagordakis E, Galvão EL, Douglas-de-Oliveira DW, Falci SGM. Relationship between Sjögren syndrome and periodontal status: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(3):223–31.
Bolstad AI, Skarstein K. Epidemiology of Sjögren’s syndrome-from an oral perspective. Curr Oral Health Rep. 2016;3(4):328–36.
Ergun S, Cekici A, Topcuoglu N, Migliari DA, Külekçi G, Tanyeri H, Isik G. Oral status and Candida colonization in patients with Sjögren’s syndrome. Med Oral Patol Oral Cir Bucal. 2010;15(2):e310–5.
Cartee DL, Maker S, Dalonges D, Manski MC. Sjögren’s syndrome: oral manifestations and treatment, a dental perspective. J Dent Hyg. 2015;89(6):365–71.
Thorne I, Sutcliffe N. Sjögren’s syndrome. Br J Hosp Med (Lond). 2017;78(8):438–42.
Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X. EULAR-Sjögren Syndrome Task Force Group. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3–18.
Hsu CY, Hung KC, Lin MS, Ko CH, Lin YS, Chen TH, Lin CY, Chen YC. The effect of pilocarpine on dental caries in patients with primary Sjögren’s syndrome: a database prospective cohort study. Arthritis Res Ther. 2019;21(1):251. States what we know today in current literature.
Wu CH, Hsieh SC, Lee KL, Li KJ, Lu MC, Yu CL. Pilocarpine hydrochloride for the treatment of xerostomia in patients with Sjögren’s syndrome in Taiwan–a double-blind, placebo-controlled trial. J Formos Med Assoc. 2006;105(10):796–803.
Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H. Effectiveness of rituximab treatment in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010;62(4):960–8.
Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, Franceschini F, Lojacono A, Nascimbeni G, Santoro A, Semeraro F, Toniati P, Shoenfeld Y. Novel aspects of Sjögren’s syndrome in 2012. BMC Med. 2013;11:93.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Systemic Diseases
Rights and permissions
About this article
Cite this article
Casella, S., Brusca, G., Messina, P. et al. Sjögren Syndrome and Periodontal Disease: State of the Art and Narrative Review of Current Literature. Curr Oral Health Rep 8, 90–95 (2021). https://doi.org/10.1007/s40496-021-00303-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40496-021-00303-8